PIA
CTSO icon

Piedmont Investment Advisors’s Cytosorbents Corp CTSO Stock Holding History

Piedmont Investment Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-493
Closed -$6K – 1332
2018
Q2 		$6K Buy
+493
New +$4.67K ﹤0.01% 2024

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Piedmont Investment Advisors's CTSO Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Cytosorbents Corp (CTSO) in Q3 2018, closing a stake of 493 shares — an estimated $6K sold.

Piedmont Investment Advisors first reported a position in CTSO in Q2 2018 and held it in 1 quarter. The position peaked at $6K in Q2 2018. 79 funds tracked by Wall St. Rank hold CTSO as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Cytosorbents Corp position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 493 Cytosorbents Corp shares in Q3 2018, an estimated $6K.
  • Piedmont Investment Advisors first reported a position in Cytosorbents Corp in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Cytosorbents Corp position peaked at $6K in Q2 2018.
  • 79 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.